BC cell line assays validated the trend of increased PAPP-A leading to higher aggressiveness and the study found further significance of the PAPP-A/IGF axis in BC, demonstrating that motility can be altered by manipulating components of the IGF axis. The gene discussed is IGF1; the disease is breast cancer.